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Polycystic  ovary  syndrome (PCOS)  is  considered  as  one  of  the leading  endocrine disorders  during
reproductive age in women. This study designed  to determine the  therapeutic effects  of red clover
(Trifolium pratense) on letrozole-induced PCOS in vivo. Forty female Sprague–Dawley rats were equally
divided into five groups. Control group with a regular sexual cycle received normal saline (letrozole
vehicle). Letrozole (1 mg/kg) was used to induce the PCOS to the rats in the treatment groups. After
induction of PCOS, four treatment groups received the normal saline, or clomiphene citrate (1 mg/kg),
or  red  clover  extracts  (500  or  750  mg/kg)  for  30-days.  After  treatment,  ovary  and  uterus  were
removed, weighed, and the ovaries were subjected to histopathological studies. Serum testosterone
and estradiol levels, antioxidant activities, and lipid profiles were evaluated. Red clover extracts and
clomiphene citrate decreased testosterone levels and showed a significant increase in estradiol levels
in comparison to PCOS induced group (p<0.05). Red clover administration restored the GSH, SOD and
CAT levels (p<0.05) and decreased the NO and MDA levels (p<0.05). Treatments caused no significant
change in levels of TG, TC, and FBG factors when compared to PCOS induced group (P>0.05). However,
red clover (750 mg/kg) significantly increased HDL and decreased LDL levels when compared to PCOS
induced  group  (P<0.05).  Treatment  with  red  clover  reduced  ovarian  weight,  volumes  of  ovarian,
medulla, cortex and number of cysts and increased number of oocytes compared to PCOS group. Both
red clover and clomiphene citrate could treat the letrozole induced PCOS in rats; however, red clover
indicated antioxidant activities more than clomiphene citrate. Red clover may be used for discovering
anti-PCOS drugs with lower side effects.
Introduction
Polycystic ovary syndrome (PCOS) is one of the most
common endocrine disorders in females. PCOS affects
an estimated 4 to 15% of women in their reproductive
age (1, 2); however, the aetiology and pathogenesis of
this  syndrome  remain  poorly  understood.  The
features  of  this  syndrome  are  infertility,  alopecia,
irregular menstrual cycles, acne and hirsutism (3, 4),
and  also  metabolic  disorders  (insulin  resistance,
obesity  and  dyslipidemia),  type  2  diabetes,  cancer,
coronary heart diseases, and hypertension (5, 6).
Changing  the  habits  of  life,  surgery,  and
medication  are  widely  followed  therapies  for  PCOS.
The  most  recognized  medications  are  clomiphene
citrate therapy, metformin, and tamoxifen(7, 8). There
are a variety of side effects such as arthritis,  muscle
pain and psychological disturbance in drugs that have
been used for management of PCOS (9, 10). Due to side
effects caused by chemical drugs, the medicinal plants
are gaining interest in the prevention and treatment
of  diseases  (11-13).  Therefore,  the  present  focus  is
being laid on natural medicinal plants with minimum
side effects.
Red  clover  with  scientific  name  Trifolium
pratense  L.  is  one  of  250  different  species  of  the
Trifolium genus, which belongs to the Leguminosae or
Fabaceae  plant  family  (14).Red  clover  has  a  wide
variety of biological potential in traditional medicine
such  as  anti-cancer,  antioxidant,  estrogenic  and
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progestogenic  activities  (15,  16).  The  aerial  part  of
this plant has four isoflavones including biochanin A,
formononetin,  genistein,  and  daidzein  (17).  These
phytochemicals have shown a lot of interest due to
their human health benefits.  Red clover isoflavones
are  estrogen  receptor  beta,  strong  agonists.  They
have selective estrogen receptor modulator potential
and  consequence,  display  a  positive  effect  on
menopausal symptoms (18). In addition, isoflavones
belong  to  phytoestrogen  class  are  useful  for  the
treatment  of  cardiovascular  disease,  osteoporosis,
menopausal  symptoms,  and  even  cancer  (19).
Regarding  to  the  effects  of  the  red  clover  and  its
compounds on human health, the aim of this study
was to evaluate the therapeutic efficacy of red clover
on letrozole-induced polycystic ovary syndrome.
Materials and Methods
Herbal extract preparation
Red clover (Trifolium pratense L.) was collected from
Yasuj (Iran) in June 2016. The plant identified in the
Herbal Medicinal Research Center of Yasuj University
of Medical Sciences (Voucher no. HMRC-r 15). Plant
materials  were extracted with 70% (v/v) ethanol by
maceration method at room temperature for 24h. 
Grouping and treatments
In this study, adult female Sprague-Dawley rats were
acquired from Shiraz Animal House and were kept in
the room at controlled conditions of temperature 25 ±
2°C, 56 ± 5 humidity and 12-h daily cycle for 7 days to
be acclimatized. They were fed with the conventional
pellet  food  (Behparvar  Com.,  Iran)  and  water  ad
libitium during of study. All procedures of the study
were  performed  according  to  the  approved  local
Animals  Ethics  Committee  (Protocol  approval
number: 150/2014).
Forty female Sprague–Dawley rats with regular
estrus cyclicity were equally divided into 5 groups of
8 rats  each. During the experiment,  the rat's  estrus
cycle  was  determined  on  each  group  by  vaginal
smear using Giemsa stain to confirm the induction of
PCOS. If the rats exhibited acyclic/irregular ovarian
cyclicity,  they  were  considered  as  PCOS  positive.
Induction  of  polycystic  ovary  syndrome  was
performed  using  letrozole  (Femara,  Novartis,
Istanbul,  Turkey) administered to the rats (1mg / kg
dissolved in 0.9% NaCl solution) p.o. once daily for 21
consecutive days (20). 
Animal  models  of  PCOS  has  offered  a  useful
method for pathophysiology study of the syndrome.
Presently,  these models  including  administration of
Estradiol  Valerate,  DHEA,  prepubertal  androgen
excess  and  letrozole  have  been  developed.  These
models  mimic  mainly  features  of  PCOS  in  women
(21).
Letrozole  is  a  potent  non-steroidal  aromatase
inhibitor.  It  used as  a PCOS model  in some animal
experiment  with  many  histologic  and  biochemical
finding similarity with human PCOS. In the most of
the experimental research for inducing of PCOS using
400 μg/day letrozole for 7-35 days (22).
Control or normal group with a regular sexual
cycle that received normal saline (letrozole vehicle)
orally  for  21  days.  All  the  experimental  animals
except  control  group were received letrozole.  After
21 days, rats were divided into 4 groups as follows:
PCOS:  rats  were  given  21  days  letrozole  and
afterward 30-day normal  saline.  Standard:  Animals
received  letrozole  for  21  days  and  afterward
administered with clomiphene citrate at a dose of 1
mg/kg in 0.9% NaCl solution per oral. Red clover (RC)-
500:  was  given  21  days  letrozole  and  afterward
treated with 500 mg/kg red clover extract orally for
30  days.  RC-750:  was  given  21  days  letrozole  and
afterward treated with 750 mg/kg red clover extract
orally for 30 days.
Blood sampling and biochemical assessments
The animals were evaluated according to a relative
number of leukocytes, epithelial and cornified cells,
24 hours after the last  sex cycle.  The animals were
anesthetized with diethyl  ether the last  dose of the
treatment after 24 h fasting and 3-5 ml of blood was
collected  by  cardiac  puncture.  Finally,  animals
sacrificed and the ovary and uterus were removed,
weighed  and  the  ovaries  were  fixed  10%  buffered
formalin and processed for histopathological study.
Serum was separated immediately and kept in a
freezer  at  −20oC  for  an  estimate  of  biochemical
parameters.  Serum testosterone and estradiol  were
measured  with  commercially  available  ELISA  kits.
The  assays  were  performed  according  to  the
manufacturer’s instructions.
The activity of superoxide dismutase (SOD) was
determined by spectrophotometer. The SOD activity
was  expressed  in  unit's/mg  protein  (23).  Catalase
(CAT) activity was estimated according to the method
Beers  and Sizer  by  spectrophotometer.  One unit  of
the  enzyme  was  defined  as  m  moles  of  H2O2
degraded/min/mg of protein (24).
Glutathione  (GSH)  content  was  determined
according to Jollow et al. (1974) method. The contents
were expressed in micromoles/mg protein (25). MDA
levels were estimated via thiobarbituric acid reacting
substance (TBARS). The MDA levels  were expressed
in micromoles/mg protein (26).
Nitrate/nitrite  was  assayed  according  to  the
method of Green et al.  (1982)  method using Griess.
The results were expressed as micromoles/mg protein
(27).
Lipid profile [triglycerides (TG), total-cholesterol
(TC),  LDL-cholesterol  (LDL-C)  and  HDL-cholesterol
(HDL-C)]  and  FBG  were  measured  according  to
commercial Iranian diagnostics kits in autoanalyzer.
Stereological study
The volume of the ovary
To estimate the volume of the ovary, the ovary was
sectioned  into  isotropic  uniform  random  (IUR)
sections  using  the  isotropic  Cavalieri  method and
using a stereomicro-scope connected to a computer,
at the final magnification of 20X. A brief description
is  presented under Figure 8  (28).  The volume was
determined via the following formula:
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Ovary volume = Σ ni = p × T× a(p). 
Where  Σ ni  =  p  considers  as  the  total  number  of
points  superimposed on the images;  T  considers  as
the distance between the sampled sections, and a(p)
considers as the area associated with each point. 
The volume of cortex, medulla, ovarian cysts
The point  counting technique was used to compute
the volume of the structures via the following rule:
Volume of the structures = ΣP (structure) / ΣP (total)
Where  ΣP (structure)  and  ΣP (total)  consider as the
total  points  striking the aim structure and the total
points striking the ovary sections, respectively. 
Estimation of the number of oocytes
The number of atretic oocytes, antral and preantral
was determined using a light microscope. The ovary
specimens  from  all  experimental  groups  were
sectioned  into  5  µm  thicknesses,   stained  with
hematoxylin-eosin  (HE)  and  pathological-
physiological  structures  were  studied  on  a  PC  in
conjunction with a (Nikon E200 microscope,  Tokyo,
Japan) with a 60 × oil immersion objective.
Statistical methods
The collected data were statistically analyzed by one-
way ANOVA followed by post hoc analysis. Tests were
carried out in triplicate. The data were expressed as
the Mean ± S.D.  The P value less than 0.05 considered
as significant.
Results and Discussion
In  the  present  study  was  aimed  to evaluate  the
therapeutic efficacy of red clover (Trifolium pratense)
on  letrozole-induced  PCOS in  rats,  both  red  clover
and  clomiphene  citrate  could  treat  the  letrozole
induced PCOS in rats; however, red clover indicated
higher antioxidant activities than clomiphene citrate.
The serum level of testosterone was significantly
increased  in  PCOS-induced  rats  group  by  letrozole
(p<0.001)  at  the  terminal  day  of  the  study  in
comparison  to  control  group.  Red  clover  and
clomiphene  citrate  (p<0.001)  successfully  restored
testosterone  levels  in  comparison  to  PCOS  induced
group (Fig. 1). 
Induction  of  PCOS  indicated  a  significant
decrease (p<0.001) in estradiol level at the last day of
the  study.  Oral  administration  of  red  clover  and
clomiphene citrate showed a significant increase in
estradiol levels in comparison to PCOS rats (Fig. 2).
In PCOS induced group, levels of TG, TC, and FBG
increased;  but  it  was  no  significantly  (P>0.05)  in
comparison to control rats (Fig. 3). However, LDL and
HDL  levels  were  markedly  restore  (P<0.05)  in
comparison to PCOS induced group (Fig. 4).
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Fig. 1. Effect of red clover extract on serum concentrations of 
testosterone in letrozole-induced PCOS rats. 
Control: Normal saline recipient; PCOS: Letrozole recipient; RC-500:
Red  clover  500  mg/kg  recipient;  RC-750:  Red  clover  750  mg/kg
recipient. Statistical analysis was carried out by one-way ANOVA
followed by Tukey’s  multiple.#  denotes  statistical  significance in
comparison to normal group rats  *denotes statistical significance
in comparison to PCOS group  rats  ### p<0.001; ***P<0.001.
Fig. 2.  Effect of red clover treatment on serum concentrations 
of estradiol in  letrozole-induced PCOS rats.
Control:  Normal  saline  recipient;  PCOS:  Letrozole  recipient;   RC-
500: Red clover 500 mg/kg recipient; RC-750: Red clover 750 mg/kg
recipient. Statistical analysis was carried out by one-way ANOVA
followed by Tukey’s multiple.
# denotes statistical significance in comparison to normal roup rats
*denotes statistical significance in comparison to PCOS group rats 
###p<0.001; *P<0.05, **P<0.01, ***P<0.001
Fig. 3. Effect of red clover treatment on serum concentrations 
of TG, 
TC and FBG in letrozole-induced PCOS rats. Control: Normal saline
recipient; PCOS: Letrozole recipient; RC-500: Red clover 500 mg/kg
recipient;  RC-750:  Red  clover  750  mg/kg  recipient.  Statistical
analysis was carried out by one-way ANOVA followed by Tukey’s
multiple.
In  comparison  to  control  rats,  PCOS  rats
significantly  indicated  an  elevation  (p<0.05)  in  NO
and  MDA  levels.  Treatment  with  red  clover
significantly  (p<0.05)  decreased  the  MDA  and  NO
levels in treatment rats (Fig. 5).
Administration  of  letrozole  decreased  (p<0.05)
the SOD, CAT activities, and GSH levels in PCOS rats
in  comparison  to  control  rats.  In  comparison  to
vehicle-treated PCOS rats,  red clover administration
significantly  increased  (p<0.05)  the  SOD  and  CAT
activities  (P<0.05).  Red  clover  successfully  restores
the GSH levels (P<0.05) (Fig. 6).
In order to develop polycystic ovary syndrome,
letrozole,  a  non-steroidal  aromatase  inhibitor  was
used.  In  this  case,  androgens  cannot  convert  to
estrogens and resulted in the elevation of androgen
and consequently fall in estrogen levels(29). Besides,
the  increased  level  of  testosterone  in  plasma,  that
resulted  in  prolonged  diestrus  phase  and  it  was
followed  by  an  increase  in  body  weight  of  PCOS
group  rats  (30,  31).  Administration  of  long-term
herbal extracts with phytoestrogens compounds can
reduce  plasma  testosterone  levels  by  the  negative
feedback effect on LH hormone (32). Administration
of  red  clover  extract  was  able  to  normalize
testosterone  and  estradiol  concentration  in
comparison to PCOS rats group. According to earlier
reports,  red  clover  with  antiandrogenic  properties
and  high  content  of  phytoestrogens  such  as
isoflavones in the plant may reduce androgen levels.
Red clover isoflavones are weak agonists of estrogen
alpha receptors (ERα) and potent agonists of estrogen
beta  receptors  (33).  Moreover,  the  phytochemical
compounds  of  red  clover  such  as  genistein  and
daidzein could interfere with steroid formation in rat
adrenal  and  consequence  decreased  testosterone
levels  (34,  35).  In  addition,  coumestrol,  biochanin,
phytoestrogens  and  zearalenol  have  inhibitory
effects  on steroidogenic enzyme activity of 17 beta-
hydroxysteroid  dehydrogenases  (17β-HSD)  which
result in reduced androgens synthesis (36).
In  the  present  study,  treatments  caused  no
significant change in levels of TG, TC, and FBG factors
as compared to PCOS induced group. However, red
clover  (750 mg/kg)  significantly  increased HDL and
decreased  LDL  levels  when  compared  to  in  PCOS
induced group. Letrozole-induced PCOS rats did not
indicate significant changes in FBG, TC, and TG levels.
The reason for this type of result was that letrozole
did  not  have  any  effects  on  insulin  signaling
pathways  (5).  In  addition,  the  letrozole-induced
rodent  model  of  PCOS did not  show any metabolic
aberrations such as adiposity, insulin sensitivity, and
dyslipidemia,  which were reported in  parallel  with
some studies (21).
Oxidative  stress  is  considered as  an  important
pathological  feature  of  PCOS. It  causes a change in
oxidant-antioxidant  profile.  Hence,  women  with
PCOS indicate a decreased level of total antioxidant
status  (37).  In  the  current  study,  oxidative  stress
markers  (MDA  and  NO)  were  increased  in  PCOS
animals.  However,  endogenous  antioxidants  (SOD,
CAT  and  GSH  levels)  in  blood  were  decreased.
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Fig. 4. Effect of red clover treatment on serum concentrations 
of HDL and LDL in letrozole-induced PCOS rats.
Control:  Normal  saline  recipient;  PCOS:  Letrozole  recipient;  RC-
500:Red clover 500 mg/kg recipient;  RC-750: Red clover 750 mg/kg
recipient. Statistical analysis was carried out by one-way ANOVA
followed by Tukey’s multiple.
# denotes  statistical  significance in comparison to  normal  group
rats.
*denotes statistical significance in comparison to PCOS group rats
#p<0.05; *P<0.05.
Fig. 5. Effect of red clover treatment on serum concentrations of
NO,  MDA and GSH in letrozole-induced PCOS rats.
Control; Normal saline recipient, PCOS; Letrozole recipient, RC500:
Red  clover  500  mg/kg;  RC750:  Red  clover  750  mg/kg;  Statistical
analysis was carried out by one-way ANOVA followed by Tukey’s
multiple.
# denotes  statistical  significance in comparison to  normal  group
rats.
*denotes statistical significance in comparison to PCOS group rats.
#p<0.05; *P<0.05.
Fig. 6. Effect of red clover treatment on serum concentrations 
of SOD and CAT in letrozole-induced PCOS rats.
Control; Normal saline recipient, PCOS; Letrozole recipient,  RC500:
Red  clover  500  mg/kg;  RC750:  Red clover  750  mg/kg;   Statistical
analysis was carried out by one-way ANOVA followed  by Tukey’s
multiple.
# denotes  statistical  significance in comparison to  normal  group
rats.
*denotes statistical significance in comparison to PCOS group rats. 
#p<0.05; *P<0.05.
Treatment  with  red  clover  significantly  reduced
markers of oxidative stress such as MDA and NO and
increased the level of potential antioxidant markers
such  as,  GSH,  CAT,  and  SOD  in  letrozole-induced
PCOS model of rats. SOD is an antioxidant enzyme in
live organisms. It protects the tissues and cell against
damages caused by superoxide radicals. SOD reduces
superoxide  radicals  generated  by  cell  injuries  via
conversion  of  superoxide  radicals  into  hydrogen
peroxide  (38).  Superoxide  scavenging  capacity  of
plant extract may be mostly due to the presence of
secondary phytochemicals  such as total  phenol and
flavonoids.  CAT enzyme hydrolyzes H2O2 into H2O
and 1/2  O2.  This  enzyme has  an important  role  in
protecting DNA, proteins, and cellular lipids (39). NO
is a very useful mediator in some physiological and
biologic pathways in the human body. Its antioxidant
and  antitumor  potentials  were  reported  in  the
literature (40, 41). Deviation in GSH levels could be
an early marker in the development of PCOS. GSH is
an important antioxidant present in all the cells. The
level  of  this  non-enzymatic  antioxidant  parameter
may  be  because  of  increased  turnover,  to  prevent
oxidative  damage.  It  protects  cells  against  free
radicals,  peroxides  and  other  toxic  compounds  (42,
43). Furthermore, lipid peroxidation is mostly used as
an indicator for oxidative tissue injury, which leads
to  cell  necrosis  and  inflammation.   Inflammation
results in the production of reactive oxygen species.
Therefore, the studies indicated that the incidence of
PCOS  was  closely  related  to  oxidative  stress  and
chronic  low  grade  inflammation  (44,  45).  In  the
present  research,  MDA  is  an  indicator  of  lipid
peroxidation that significantly increased in polycystic
ovaries and red clover is able to restore it. 
The ovarian weight in the PCOS group showed a
significant  increase  compared to  the  normal  group
(p<0.05) (Fig. 7). Consumption of clomiphene and red
clover extracts significantly reduced (p<0.05) ovarian
weight  compared  to  PCOS  group  (Fig.  7).  Ovarian
stereology study in PCOS group, the total volume of
the ovary, cortex, medulla, and number of cysts were
increased and a reduction is the number of oocytes
compared with the control group. Treatment with red
clover showed reduced volumes of ovarian, medulla
and  cortex.  The  number  of  cysts  and  number  of
oocytes are increased in respect of PCOS group. 
The various histological studies revealed that a
large  number  of  cystic  follicles  were  observed  in
PCOS group, however the cysts were not observed in
other groups. Growth of ovarian follicles in the early
stages  did  not  occur.  Their  granulosa  cells  were
destroyed and follicles became a cyst. Follicles were
observed  in  the  red  clover  treatment  groups  in
different stages of growth (primary, preantral, antral
and  graphs)  and  corpus  luteum  that  indicated
ovulation (Fig. 8).
The volume of the cortex and total volume of the
ovary  were  significantly  reduced  in  the  red  clover
groups  as  compared  with  the  control  rats.  These
results may be due to the absence of corpus luteum,
reduction in the number of antral follicle, increase in
the number of atretic follicles. Ovary atrophy occurs
in the PCOS rats. Furthermore, red clover may induce
oxidative stress and ovary apoptosis that can result in
a reduction in the ovary volume.
Phytoestrogen  has  a  chemical  structural
similarity  or  functional  similarity  to  estrogens  that
resulted in similar hormonal activity, it further binds
to estrogen receptors. Hence they have a protective
effect against PCOS and hormone-dependent cancers.
As isoflavones are major phenolic compounds found
in addition to phytoestrogens in red clover, probably
play important role of red clover in the prevention
and treatment of PCOS (18).
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Fig. 7. Effect of red clover treatment on ovary weight in 
letrozole induced PCOS rats.
Control; Normal saline recipient, PCOS; Letrozole recipient, RC500:
Red  clover  500  mg/kg;  RC750:  Red  clover  750  mg/kg;  Statistical
analysis was carried out by one-way ANOVA followed by Tukey’s
multiple. 
# denotes statistical  significance in comparison to normal group
rats.
*denotes statistical significance in comparison to PCOS group rats.
##p<0.01; *P<0.05.
Fig. 8. Histological sections of rat ovary were stained with 
hematoxylin and eosin in different groups (20X magnification).
Control or Normal: saline recipient, PCOS; Letrozole recipient, RC-
500: Red clover 500 mg/kg recipient; RC-750: Red clover 750 mg/kg
recipient; PF: Primary Follicle; PAF: Pre antral Follicle; AF: Antral
Follicle;  GF:  Graf  Follicle;  CL:  Corpus  Luteum;  OC:  Oocyte.
Letrozole-induced PCOS rats indicate large cystic follicles (CF); Red
clover 500 mg/kg treated PCOS rats indicate well-defined thecal cell
layer;  Red  clover  750  mg/kg  treated  PCOS  rats  indicate  normal
follicle.
Conclusion
PCOS  as  a  hormonal  disorder  common  among
women  of  reproductive  age  is  one  of  the  most
common  causes  of  female  infertility.  It  has  been
reported  that  PCOS  is  a  composite  heterogeneous
condition  with  multifactorial  etiology  like  genetic,
oxidative stress, and the environmental factors. The
study indicated that red clover as a medicinal plant
can  be  useful for  treatment  of  PCOS  similar  to
standard  drug  (clomiphene  citrate).  It  is  due  to
antioxidant properties of the plant that can be used
as a potential source for production of natural anti-
PCOS drugs with lower side effects.
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